glp-1 leaky gut Glucagon-like peptide-1 (GLP-1), released from the intestine, informs GLP-1 Receptor Agonists in Obese

Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessivecompulsive disorder: a systematic review and meta-analysis of randomized clinical trials

Functional medicine practitioners will work to ensure an early diagnosis of your thyroid condition, and will then optimize thyroid medications (to achieve optimal versus normal TSH levels)

A study utilizing functional MRI found that administration of exenatide, a glucagon-like peptide-1 receptor agonist, decreased activation in areas such as the insula, amygdala, orbitofrontal cortex and putamen in response to food cues

Areas requiring further investigation: Signaling findings from isolated cells or engineered assay systems do not automatically predict broader biological behavior